The current survival rate is >95% in patients with germ cell tumors managed
with conservative management and chemotherapy. Before the chemotherapy era,
most patients succumbed to their disease.
germ cell tumors require postoperative chemotherapy. The most active
regimens used are vinblastine, bleomycin, and cisplatin. Follow-up after
conservative surgery is every three months with pelvic examination and tumor
marker measurements.